Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
2001 1
2002 1
2004 1
2005 1
2007 1
2009 2
2010 4
2011 1
2012 3
2013 7
2014 2
2015 3
2016 1
2019 2
2020 1
2021 2
2022 10
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Reduced number of intrahepatic bile ducts"
Page 1
Geospatial Immune Heterogeneity Reflects the Diverse Tumor-Immune Interactions in Intrahepatic Cholangiocarcinoma.
Lin Y, Peng L, Dong L, Liu D, Ma J, Lin J, Chen X, Lin P, Song G, Zhang M, Liu Y, Rao J, Wei C, Lu Y, Zhang S, Ding G, Peng Z, Lu H, Wang X, Zhou J, Fan J, Wu K, Gao Q. Lin Y, et al. Cancer Discov. 2022 Oct 5;12(10):2350-2371. doi: 10.1158/2159-8290.CD-21-1640. Cancer Discov. 2022. PMID: 35853232
Intrahepatic cholangiocarcinoma (iCCA) exhibits extensive intratumoral heterogeneity and an extremely high mortality rate. ...Notably, FGFR2 mutations and fusions correlated with low mutation burden and reduced immune infiltration. Our work delineated the dynamic tu …
Intrahepatic cholangiocarcinoma (iCCA) exhibits extensive intratumoral heterogeneity and an extremely high mortality rate. ...Notably …
Epidemiology of cholangiocarcinoma: an update focusing on risk factors.
Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST. Shin HR, et al. Cancer Sci. 2010 Mar;101(3):579-85. doi: 10.1111/j.1349-7006.2009.01458.x. Epub 2009 Dec 4. Cancer Sci. 2010. PMID: 20085587 Free PMC article. Review.
Cholangiocarcinoma is relatively rare, but high incidence rates have been reported in Eastern Asia, especially in Thailand. The etiology of this cancer of the bile ducts appears to be mostly due to specific infectious agents. ...The implementation of a more intensiv …
Cholangiocarcinoma is relatively rare, but high incidence rates have been reported in Eastern Asia, especially in Thailand. The etiology of …
Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans.
Kim JA, Park SJ, Choi S, Chang J, Jeong S, C Ahn J, Lee G, Son JS, Park SM. Kim JA, et al. Sci Rep. 2022 Jun 14;12(1):9856. doi: 10.1038/s41598-022-14147-4. Sci Rep. 2022. PMID: 35701586 Free PMC article.
A number of studies have proposed an inverse association between allergic diseases and risk of cancer, but only a few studies have specifically investigated the risk of primary liver cancer, including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinom …
A number of studies have proposed an inverse association between allergic diseases and risk of cancer, but only a few studies have sp …
Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
Sakano Y, Noda T, Kobayashi S, Kitagawa A, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Asaoka T, Tanemura M, Umeshita K, Mimori K, Doki Y, Eguchi H. Sakano Y, et al. Dig Dis Sci. 2022 Aug;67(8):3817-3830. doi: 10.1007/s10620-021-07266-x. Epub 2021 Oct 9. Dig Dis Sci. 2022. PMID: 34626299
BACKGROUND: Combined hepatocellular and cholangiocarcinoma is a rare primary liver cancer with histological features of both hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Little is known about the prognostic features and molecular mechanism of cHCC-iCCA. .. …
BACKGROUND: Combined hepatocellular and cholangiocarcinoma is a rare primary liver cancer with histological features of both hepatocellular …
Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study.
Chen C, Su J, Wu H, Qiu Y, Song T, Mao X, He Y, Cheng Z, Zhai W, Li J, Geng Z, Tang Z. Chen C, et al. Eur J Surg Oncol. 2023 Apr;49(4):780-787. doi: 10.1016/j.ejso.2022.11.008. Epub 2022 Nov 8. Eur J Surg Oncol. 2023. PMID: 36404249 Free article.
BACKGROUND: This study aimed to evaluate the prognostic value of lymph node dissection (LND) in node-negative intrahepatic cholangiocarcinoma (ICC) and identify the appropriately total number of lymph nodes examined (TNLE). ...Overall survival (OS), relapse-free sur …
BACKGROUND: This study aimed to evaluate the prognostic value of lymph node dissection (LND) in node-negative intrahepatic cholangioc …
Effectiveness of ultrasound-guided percutaneous transhepatic biliary drainage to reduce radiation exposure: A single-center experience.
Park SE, Nam IC, Baek HJ, Ryu KH, Lim SG, Won JH, Kim DR. Park SE, et al. PLoS One. 2022 Nov 4;17(11):e0277272. doi: 10.1371/journal.pone.0277272. eCollection 2022. PLoS One. 2022. PMID: 36331963 Free PMC article.
Fluoroscopy time and the reported radiation dose were significantly lower in patients with dilated bile ducts than in those with non-dilated bile ducts, when biliary puncture under US guidance was performed initially. However, even in patients with non …
Fluoroscopy time and the reported radiation dose were significantly lower in patients with dilated bile ducts than in those wi …
Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort.
Zhang D, Qi F, Sun W, Zhao G, Wang D, Zhou S, Liu Z, Lu Z. Zhang D, et al. Eur J Med Res. 2022 Oct 28;27(1):214. doi: 10.1186/s40001-022-00851-4. Eur J Med Res. 2022. PMID: 36307886 Free PMC article.
Logistic regression analysis indicated that age 65 years (OR 2.035, 95%CI 1.131-3.007), preoperative cholangitis (OR 1.584, 95% CI 1.081-2.361), number of biliary anastomosis 2(OR 2.866, 95%CI 1.942-3.624), GGT on the first day after surgery 120 U/L (OR 1.823, 95%CI: 1.274 …
Logistic regression analysis indicated that age 65 years (OR 2.035, 95%CI 1.131-3.007), preoperative cholangitis (OR 1.584, 95% CI 1.081-2.3 …
Analysis of EBN Interventions in the Perioperative Period of Minimally Invasive Surgery for Intrahepatic and Extrahepatic Bile Duct Stones.
Yang Y, Qiu J, Zhu L. Yang Y, et al. Altern Ther Health Med. 2022 Oct;28(7):139-145. Altern Ther Health Med. 2022. PMID: 35839109 Free article. Clinical Trial.
Few studies have occurred on EBN interventions for patients with intrahepatic or extrahepatic bile duct stones who are in the perioperative period of minimally invasive surgery. OBJECTIVE: The study intended to investigate the benefits of EBN interventions for patie …
Few studies have occurred on EBN interventions for patients with intrahepatic or extrahepatic bile duct stones who are in the …
Effectiveness of public health interventions in reducing the prevalence of Opisthorchis viverrini: a protocol for systematic review and network meta-analysis.
Sota P, Alene KA, Andityas M, Tangkawattana S, Sripa B, Clements ACA. Sota P, et al. BMJ Open. 2022 Sep 8;12(9):e064573. doi: 10.1136/bmjopen-2022-064573. BMJ Open. 2022. PMID: 36691213 Free PMC article.
Various public health interventions have been conducted to reduce opisthorchiasis but the prevalence of O. viverrini remains high in endemic regions. ...The prevalence, incidence or number of O. viverrini-infected people will be used as the source of O. viverrini pr …
Various public health interventions have been conducted to reduce opisthorchiasis but the prevalence of O. viverrini remains high in …
Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer.
Malik IA, Rajput M, Werner R, Fey D, Salehzadeh N, von Arnim CAF, Wilting J. Malik IA, et al. BMC Cancer. 2022 Nov 19;22(1):1193. doi: 10.1186/s12885-022-10247-6. BMC Cancer. 2022. PMID: 36402986 Free PMC article.
The incidence of primary liver tumors, hepatocellular carcinoma (HCC), intrahepatic cholangiocellular carcinoma (ICC), and combined HCC/ICC (cHCC/CC) is increasing. ...Sorafenib inhibited proliferation of all cells, except the ECC line CCC5. However, at reduced dosa …
The incidence of primary liver tumors, hepatocellular carcinoma (HCC), intrahepatic cholangiocellular carcinoma (ICC), and combined H …
40 results